AmSurg’s $7.8B offer rejected by TeamHealth

Knoxville, Tenn.-based TeamHealth quickly rejected an offer Tuesday to merge with Nashville, Tenn.-based AmSurg for a total enterprise value of $7.8 billion, or $71.47 per share, according to Reuters.

Advertisement

The ambulatory surgical center company, looking to bulk up as the industry consolidates, offered to pay $5.3 billion for the merger and to back TeamHealth’s recent acquisition of North Hollywood, Calif.-based IPC Healthcare for $1.4 billion, according to the report.

The combined company — which would include 1,200 healthcare facilities and 20,000 clinicians — would continue under the TeamHealth name and be led by AmSurg CEO Christopher Holden, according to the report.

TeamHealth reportedly denied the cash-and-stock offer because it undervalued the company, according to Reuters.

 

More articles on transactions and valuation:

6 recent hospital transactions and partnerships
CHS to sell Florida hospital to BayCare
Gardens Regional Hospital & Medical Center enters partnership for management services: 5 things to know

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Transactions & Valuation Issues

Advertisement

Comments are closed.